Showing results (531-540 of 627) with videos related to

Sort By:
Pageof 63
Anesthesiology|May 31, 2020
Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled TrialVittoria Arslan-Carlon, Kay See Tan, Guido Dalbagni, et al.
Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.
Toxicology and Applied Pharmacology|October 13, 2004
Neurotoxicity of carbonyl sulfide in F344 rats following inhalation exposure for up to 12 weeksDaniel L Morgan, Peter B Little, David W Herr, et al.
Toxicology and Applied Pharmacology|December 16, 2014
Assessment of serum biomarkers in rats after exposure to pesticides of different chemical classesVirginia C Moser, Nicholas Stewart, Danielle L Freeborn, et al.
Environmental Health Perspectives|October 6, 2005
Air pollution and lymphocyte phenotype proportions in cord bloodIrva Hertz-Picciotto, Caroline E W Herr, Poh-Sin Yap, et al.
Clinical Genitourinary Cancer|August 14, 2017
Clinical Outcomes of Patients With T1 Nested Variant of Urothelial Carcinoma Compared to Pure Urothelial Carcinoma of the BladderAbhijith D Mally, Amy L Tin, Justin K Lee, et al.
The Journal of Urology|March 1, 1988
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
Neurotoxicology|July 8, 2024
Identification of neural-relevant toxcast high-throughput assay intended gene targets: Applicability to neurotoxicity and neurotoxicant putative molecular initiating eventsCina M Mack, Alethea Tsui-Bowen, Alicia R Smith, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCCWassim Kassouf, Piyush K Agarwal, Harry W Herr, et al.
Pageof 63